Intersect ENT, Inc. Embedded Derivative, Fair Value of Embedded Derivative Liability
Intersect ENT, Inc. had Embedded Derivative, Fair Value of Embedded Derivative Liability of $16.20 million as of 2022-03-31, per its 10-Q filed 2022-05-04.
Discontinued › Notes › Embedded Derivative
us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability · last filed 2022-05-04
- 2022-03-31: Embedded Derivative, Fair Value of Embedded Derivative Liability $16.20M.
- 2021-12-31: Embedded Derivative, Fair Value of Embedded Derivative Liability $16.20M.
- 2021-09-30: Embedded Derivative, Fair Value of Embedded Derivative Liability $15.80M.
- 2021-06-30: Embedded Derivative, Fair Value of Embedded Derivative Liability $2.70M.
| Period end | Embedded Derivative, Fair Value of Embedded Derivative Liability |
|---|---|
| 2022-03-31 | $16.20M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $16.20M 10-Q · filed 2022-05-04 |
| 2021-09-30 | $15.80M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $2.70M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $3.40M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $3.00M 10-K · filed 2021-03-09 |
| 2020-09-30 | $2.60M 10-Q · filed 2020-11-02 |
| 2020-06-30 | $3.60M 10-Q · filed 2020-08-05 |